{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:51:41Z","timestamp":1789563101302,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.ygyno.2020.04.047","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T09:02:55Z","timestamp":1588064575000},"page":"613-618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Performance of lymphadenectomy for apparent early stage malignant ovarian germ cell tumors in the era of platinum-based chemotherapy"],"prefix":"10.1016","volume":"157","author":[{"given":"Dimitrios","family":"Nasioudis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily M.","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley F.","family":"Haggerty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Cory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Robert L.","family":"Giuntoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawar A.","family":"Latif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9 Suppl 3","key":"10.1016\/j.ygyno.2020.04.047_bb0005","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1097\/IGC.0000000000000223","article-title":"Gynecologic Cancer Intergroup (GCIG) consensus review for ovarian germ cell tumors","volume":"24","author":"Brown","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2020.04.047_bb0010","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ygyno.2012.03.019","article-title":"Current advances in the management of malignant germ cell and sex cord-stromal tumors of the ovary","volume":"125","author":"Gershenson","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2020.04.047_bb0015","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.6004\/jnccn.2016.0122","article-title":"Ovarian cancer, version 1.2016, NCCN clinical practice guidelines in oncology","volume":"14","author":"Morgan","year":"2016","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"3","key":"10.1016\/j.ygyno.2020.04.047_bb0020","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/IGC.0000000000000341","article-title":"Lower limb lymphedema and neurological complications after lymphadenectomy for gynecological cancer","volume":"25","author":"Biglia","year":"2015","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2020.04.047_bb0025","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ygyno.2016.08.329","article-title":"Conundrums in the management of malignant ovarian germ cell tumors: toward lessening acute morbidity and late effects of treatment","volume":"143","author":"Gershenson","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2020.04.047_bb0030","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jpedsurg.2003.11.027","article-title":"Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study","volume":"39","author":"Billmire","year":"2004","journal-title":"J. Pediatr. Surg."},{"issue":"11","key":"10.1016\/j.ygyno.2020.04.047_bb0035","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.3109\/00016340903242461","article-title":"Para-aortic lymph node metastasis in malignant dysgerminoma of the ovary","volume":"88","author":"Kasenda","year":"2009","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"3","key":"10.1016\/j.ygyno.2020.04.047_bb0040","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ygyno.2017.03.023","article-title":"Analysis of outcomes and prognostic factors after fertility-sparing surgery in malignant ovarian germ cell tumors","volume":"145","author":"Park","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2020.04.047_bb0045","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/annonc\/mdw563","article-title":"The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study","volume":"28","author":"Mangili","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2020.04.047_bb0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejca.2019.03.001","article-title":"A multicentre retrospective cohort study of ovarian germ cell tumours: evidence for chemotherapy de-escalation and alignment of paediatric and adult practice","volume":"113","author":"Newton","year":"2019","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2020.04.047_bb0055","doi-asserted-by":"crossref","unstructured":"Alice Bergamini, Giorgio Giorda, Gabriella Ferrandina, et al Surveillance in stage I MOGCTs (malignant ovarian germ cell tumors): a MITO prospective study (multicenter Italian trials in ovarian cancer). Journal of Clinical Oncology 2019 37:15_suppl, 5516\u20135516.","DOI":"10.1200\/JCO.2019.37.15_suppl.5516"},{"issue":"5","key":"10.1016\/j.ygyno.2020.04.047_bb0060","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1097\/SLA.0b013e31818447cd","article-title":"Comprehensive staging allows for excellent outcome in patients with localized malignant germ cell tumor of the ovary","volume":"248","author":"Palenzuela","year":"2008","journal-title":"Ann. Surg."},{"issue":"4","key":"10.1016\/j.ygyno.2020.04.047_bb0065","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/bjc.2011.267","article-title":"Prognostic impact of lymphadenectomy in clinically early stage malignant germ cell tumour of the ovary","volume":"105","author":"Mahdi","year":"2011","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2020.04.047_bb0070","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ygyno.2013.08.016","article-title":"The significance of comprehensive staging surgery in malignant ovarian germ cell tumors","volume":"131","author":"Liu","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.04.047_bb0075","doi-asserted-by":"crossref","unstructured":"Ray-Coquard I, Morice P, Lorusso D, et al. Non-epithelial ovarian cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018 Oct 1;29(Suppl4):iv1-iv18.","DOI":"10.1093\/annonc\/mdy001"},{"issue":"5","key":"10.1016\/j.ygyno.2020.04.047_bb0080","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/IGC.0000000000000702","article-title":"Outcomes of surgery alone and surveillance strategy in young women with stage I malignant ovarian germ cell tumors","volume":"26","author":"Park","year":"2016","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2020.04.047_bb0085","doi-asserted-by":"crossref","unstructured":"Terenziani M, Bisogno G, Boldrini R, et al Malignant ovarian germ cell tumors in pediatric patients: the AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) study. Pediatr Blood Cancer. 2017 Nov;64(11).","DOI":"10.1002\/pbc.26568"},{"issue":"2","key":"10.1016\/j.ygyno.2020.04.047_bb0090","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ygyno.2011.01.006","article-title":"Is surgical restaging indicated in apparent stage IA pure ovarian dysgerminoma? The MITO group retrospective experience","volume":"121","author":"Mangili","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2020.04.047_bb0095","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1200\/JOP.19.00431","article-title":"Magic still needed for germ cell tumor research, especially in adolescents and young adults","volume":"15","author":"Bleyer","year":"2019","journal-title":"J Oncol Pract."},{"issue":"3","key":"10.1016\/j.ygyno.2020.04.047_bb0100","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.ygyno.2007.01.042","article-title":"Quality of life in long-term survivors of ovarian germ cell tumors: a Gynecologic Oncology Group study","volume":"105","author":"Champion","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2020.04.047_bb0105","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/pon.1437","article-title":"Fear of recurrence in long-term testicular cancer survivors","volume":"18","author":"Skaali","year":"2009","journal-title":"Psychooncology"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820303061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820303061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:50:17Z","timestamp":1758772217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825820303061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0090825820303061"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.04.047","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance of lymphadenectomy for apparent early stage malignant ovarian germ cell tumors in the era of platinum-based chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.04.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}